| 1 |
35146591 | Susceptibility of Lung Carcinoma Cells to Nanostructured Lipid Carrier of ARV-825, a BRD4 Degrading Proteolysis Targeting Chimera. | 2022 Feb 10 |
1 |
| 2 |
33888130 | BRD4 PROTAC degrader ARV-825 inhibits T-cell acute lymphoblastic leukemia by targeting 'Undruggable' Myc-pathway genes. | 2021 Apr 22 |
2 |
| 3 |
32559187 | Multiple myeloma: Combination therapy of BET proteolysis targeting chimeric molecule with CDK9 inhibitor. | 2020 |
1 |
| 4 |
30606790 | Proteolysis targeting chimeric molecules as therapy for multiple myeloma: efficacy, biomarker and drug combinations. | 2019 Jun |
1 |